Place of Colistin-Rifampicin Association in the Treatment of Multidrug-Resistant Acinetobacter Baumannii Meningitis: A Case Study

Overview

Journal Case Rep Infect Dis

Publisher Wiley

Specialty Infectious Diseases

Date 2016 Apr 12

PMID 27064923

Citations 2

Authors

Dahraoui Souhail

Belefquih Bouchra

Badia Belarj

Rar Laila

Frikh Mohammed

Oumarou Mamane Nassirou

Ibrahimi Azeddine

Charki Haimeur

Abdelhay Lemnouer

Mostafa Elouennass

Affiliations

Soon will be listed here.

Abstract

Treatment of Acinetobacter baumannii meningitis is an important challenge due to the accumulation of resistance of this bacteria and low meningeal diffusion of several antimicrobial requiring use of an antimicrobial effective combination to eradicate these species. We report a case of Acinetobacter baumannii multidrug-resistant nosocomial meningitis which was successfully treated with intravenous and intrathecal colistin associated with rifampicin.

Citing Articles

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of....

Tsuji B, Pogue J, Zavascki A, Paul M, Daikos G, Forrest A Pharmacotherapy. 2019; 39(1):10-39.

PMID: 30710469 PMC: 7437259. DOI: 10.1002/phar.2209.

Therapeutic drug monitoring for colistin therapy in severe multi-resistant intracerebral abscess: A single case study with high-dose colistin and review of literature.

Tafelski S, Wagner L, Angermair S, Deja M SAGE Open Med Case Rep. 2017; 5:2050313X17711630.

PMID: 28680633 PMC: 5480626. DOI: 10.1177/2050313X17711630.

References

Rodriguez Guardado A, Maradona J, Asensi V, Carton J, Perez F, Blanco A . [Postsurgical meningitis caused by Acinetobacter baumannii: study of 22 cases and review of the literature]. Rev Clin Esp. 2001; 201(9):497-500. DOI: 10.1016/s0014-2565(01)70895-8. View

Metan G, Alp E, Aygen B, Sumerkan B . Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother. 2007; 60(1):197-9. DOI: 10.1093/jac/dkm181. View

Giamarellos-Bourboulis E, Xirouchaki E, Giamarellou H . Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2001; 40(3):117-20. DOI: 10.1016/s0732-8893(01)00258-9. View

Pachon-Ibanez M, Fernandez-Cuenca F, Docobo-Perez F, Pachon J, Pascual A . Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam. J Antimicrob Chemother. 2006; 58(3):689-92. DOI: 10.1093/jac/dkl303. View

Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I . Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care. 2003; 7(5):R78-83. PMC: 270720. DOI: 10.1186/cc2358. View

Levin A, Barone A, Penco J, Santos M, Marinho I, Arruda E . Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis. 1999; 28(5):1008-11. DOI: 10.1086/514732. View

Jimenez-Mejias M, Marquez-Rivas F, Martin-Lozano D, Prados T, Pachon J . Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis. 2002; 21(3):212-4. DOI: 10.1007/s10096-001-0680-2. View

Gulati S, Kapil A, Das B, Dwivedi S, Mahapatra A . Nosocomial infections due to Acinetobacter baumannii in a neurosurgery ICU. Neurol India. 2001; 49(2):134-7. View

Bassetti M, Ginocchio F, Mikulska M . New treatment options against gram-negative organisms. Crit Care. 2011; 15(2):215. PMC: 3219411. DOI: 10.1186/cc9997. View

10.

Murray C, Hospenthal D . Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis. 2005; 18(6):502-6. DOI: 10.1097/01.qco.0000185985.64759.41. View

11.

Huttova M, Freybergh P, Rudinsky B, Sramka M, Kisac P, Bauer F . Postsurgical meningitis caused by Acinetobacter baumannii associated with high mortality. Neuro Endocrinol Lett. 2007; 28 Suppl 2:15-6. View

12.

Karaiskos I, Galani L, Baziaka F, Katsouda E, Ioannidis I, Andreou A . Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Int J Antimicrob Agents. 2013; 41(5):480-3. DOI: 10.1016/j.ijantimicag.2013.02.010. View

13.

Michalopoulos A, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas M . Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect. 2005; 11(2):115-21. DOI: 10.1111/j.1469-0691.2004.01043.x. View

14.

Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez F, Barrero-Almodovar A, Garcia-Garmendia J, Bernabeu-WittelI M . Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis. 2003; 36(9):1111-8. DOI: 10.1086/374337. View

15.

Rodriguez Guardado A, Blanco A, Asensi V, Perez F, Rial J, Pintado V . Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother. 2008; 61(4):908-13. DOI: 10.1093/jac/dkn018. View

16.

Falagas M, Fragoulis K, Kasiakou S, Sermaidis G, Michalopoulos A . Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents. 2005; 26(6):504-7. DOI: 10.1016/j.ijantimicag.2005.09.004. View

17.

Durand M, Calderwood S, Weber D, MILLER S, Southwick F, Caviness Jr V . Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993; 328(1):21-8. DOI: 10.1056/NEJM199301073280104. View

18.

Maragakis L, Perl T . Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008; 46(8):1254-63. DOI: 10.1086/529198. View

19.

Chen H, Lai C, Chan Y, Chen T, Liu C, Fung C . Clinical significance of Acinetobacter species isolated from cerebrospinal fluid. Scand J Infect Dis. 2005; 37(9):669-75. DOI: 10.1080/00365540510044076. View

20.

Streharova A, Benca J, Holeckova K, Balik J, Sula I, Lesnakova A . Comparison of postsurgical and community acquired bacterial meningitis--analysis of 372 cases within a nationwide survey. Neuro Endocrinol Lett. 2007; 28 Suppl 3:7-9. View